Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Menicon CoFRA:5FR -1.63%89 PS Ratio is 0.96 as of Aug. 02, 2026, which is 32% below its 10-year median of 1.41. GuruFocus rates FRA:5FR with a GF Score™ of 89/100 and a GF Value™ of €9.01. The stock has 3 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Menicon Co ranks better than 79.1% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Menicon Co's share price is €9.05.
Menicon Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €9.41. Hence, Menicon Co's PS Ratio for today is 0.96.
The historical rank and industry rank for Menicon Co's PS Ratio or its related term are showing as below:
FRA:5FR'
s PS Ratio Range Over the Past 10 Years
Min: 0.68 Med: 1.41 Max: 4.12
Current: 1.05
During the past 13 years, Menicon Co's highest PS Ratio was 4.12. The lowest was 0.68. And the median was 1.41.
FRA:5FR's PS Ratio is ranked better than 79.1% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.925
vs FRA:5FR: 1.05
Menicon Co Ltd has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Menicon Co was 11.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 7.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 5.50% per year.
During the past 13 years, Menicon Co's highest 3-Year average Revenue per Share Growth Rate was 8.10% per year. The lowest was 1.20% per year. And the median was 4.60% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Menicon Co PS Ratio Related Terms
Menicon Co PS Ratio Historical Data
* Premium members only.
The historical data trend for Menicon Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Menicon Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Menicon Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Menicon Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Menicon Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Menicon Co's Share Price of today is €9.05. Menicon Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.41.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Menicon Co (FRA:5FR) has a PS Ratio of 0.96 as of Aug. 02, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Menicon Co and its competitors. This is 32% below median its historical median of 1.41. Over the past decade, Menicon Co's PS Ratio has ranged from 0.68 to 4.12. According to the industry distribution chart, Menicon Co ranks #168 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 20.9%.
Is Menicon Co's PS Ratio too high?
Menicon Co's current PS Ratio of 0.96 is 32% below median its 10-year median of 1.41. Over the past 10 years, this metric has ranged from a low of 0.68 to a high of 4.12. The Medical Devices & Instruments industry median PS Ratio is 2.93. Menicon Co's value of 0.96 is 67.2% below this industry median. Based on the distribution chart, Menicon Co ranks #168 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Menicon Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Menicon Co's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Menicon Co ranks #168 out of 804 companies for PS Ratio. This places Menicon Co in the top 21% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.93. Menicon Co's value of 0.96 is 67.2% below this benchmark. Historically, Menicon Co's own PS Ratio has ranged from 0.68 to 4.12 over the past decade. While the company's 10-year median is 1.41 vs. the industry median of 2.93, Menicon Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.93, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Menicon Co's current PS Ratio of 0.96 is 67.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Menicon Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Menicon Co's current PS Ratio is 0.96, which is 32% below median its own 10-year median of 1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Menicon Co stock overvalued right now?
Menicon Co (FRA:5FR) has a current PS Ratio of 0.96. The stock's GF Value™ is €9.01, compared to a current price of €9.05 — trading 0.4% above its estimated fair value. The current PS Ratio is 0.96, which is 32% below median its 10-year median of 1.41 and 67.2% below the Medical Devices & Instruments industry median of 2.93. Menicon Co's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Menicon Co (FRA:5FR), the current PS Ratio is 0.96 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Menicon Co (FRA:5FR) Overvalued in 2026?
Based on GuruFocus' analysis, Menicon Co stock appears to be overvalued.
The current stock price of €9.05 is trading 0.4% above its estimated GF Value™ of €9.01.
Key valuation signals for FRA:5FR:
PS Ratio: 0.96 (32% below median its 10-year median of 1.41)
GF Value™: €9.01 vs. price of €9.05 (0.4% above fair value)
Industry Position: 67.2% below the Medical Devices & Instruments median (#168 of 804)
No single metric tells the full story. See the FRA:5FR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Menicon Co Ltd is a contact lens manufacturing company. It is involved in manufacturing, sales, export, and import of contact lenses and other medical goods, manufacturing and sales of medical instruments, sales of medical supplies and research and development of intraocular lenses. The firm's products include soft lenses, gas permeable lenses and lens care products.
89GF Score
Get the complete analysis for FRA:5FR
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5FR has been successfully added to your 
